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Role of MicroRNA in  
Smoking–Induced Periodontitis
Herman S. Cheung, Carlos Carballosa and Jordan Greenberg
Abstract
Stem cells participate in tissue restoration and therapies. The oral cavity, the site 
of smoking exposure, contains stem cells which are involved in the development, 
maintenance, and repair of oral tissues. By residing in the oral cavity, stem cells are 
exposed to and susceptible to the effects of smoking. Periodontitis has been associ-
ated with increased incidences of other illnesses such as cardiovascular diseases. We 
hypothesis that smoking suppression of stem cell potentials by miRNAs is a separate 
and independent pathway than the pathway via the nicotine receptor activation. 
Smoking perturbs miRNA expression, resulting in decreased stem cell regeneration 
potential that delays healing of periodontitis.
Keywords: periodontal ligament stem cells, cigarette smoking, e-cigarette vapor, 
regenerative potential
1. Introduction
Cigarette smoking (CS) is one of the leading causes of preventable death 
in the world. Despite the smoking cessation attempts in the United States (US), 
15.1% of US adults are still active smokers [1]. Cigarette smoke exposure increases 
the risk of various cancers and systemic diseases [2] in smokers; however, smoking 
is a difficult habit to quit due to the addictive property of nicotine. Nicotine replace-
ment therapies (NRT) help smokers overcome their nicotine addiction through 
gradually decreasing nicotine dose delivery regimens. Electronic cigarettes (ECs), 
marketed as a “safer alternative” to cigarette smoking, have not been fully regulated 
by the FDA and are still believed to cause major health concerns due to the concen-
trated delivery of toxic chemicals like nicotine, among others [3, 4]. Additionally, 
due to a lack of regulation, labeling and dosage of nicotine can vary widely among 
EC products. In the United States alone, EC use has doubled among US adults and 
tripled among adolescents within the last 5 years [5, 6].
Internalization of smoking- and vaping-related toxins occurs primarily through 
the respiratory system. For specific compounds like nicotine, the subsequent 
absorption into specific tissues is largely dependent on tissue pH [7]. Nicotine is 
a weak base (pKa of 8.0) and is more readily absorbed in slightly basic conditions 
where it is less “ionized” [7–9]. The oral cavity, the initial site of smoke exposure, 
is a slightly acidic environment. Cigarette smoke is more alkaline than originally 
thought [7], thereby improving oral nicotine absorption. Electronic cigarette (EC) 
liquids, on the other hand, are a slightly more basic pH [8]. Therefore, nicotine 
delivered from these devices is more readily absorbed in the mouth. Nicotine in 
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the smoker’s saliva, which traps ionized nicotine and maintains elevated levels of 
exposure in the mouth, is almost 87 times higher than in the blood plasma [10–12].
1.1 Periodontal ligament stem cells (PDLSCs)
Periodontal ligament stem cells (PDLSCs) are an adult stem cell population that 
reside in the periodontal ligament and give rise to tooth-supporting structures such 
as the alveolar bone, periodontal ligament, and cementum [13, 14]. In addition 
to their regenerative capabilities, PDLSCs can be easily isolated following natural 
tooth loss or routine dental procedures [13]. A recent clinical trial using autologous 
PDLSCs as a therapeutic approach for the regeneration of periodontal bone defects 
confirmed the safety of this approach for human use [15]. Stem cells have proven 
to be effective for the treatment of a variety of injuries and diseases. However, 
compromising stem cell function, through infectious or genetic diseases, can lead 
to ineffective clinical outcomes; therefore these conditions are included as exclusion 
criteria in patient recruitment for stem cell-based therapies. Environmental risk 
factors such as cigarette smoking and nicotine use can also compromise stem cell 
function leading to inefficacious outcomes [16–19]. This suggests that they deserve 
consideration as exclusion criteria [18, 19].
1.2 Nicotinic acetylcholine receptor
Although the effects of nicotine exposure on human health are known, its implica-
tion in regard to stem cell biology and function remains greatly unknown. Nicotinic 
acetylcholine receptor (nAChRs) are one of the mediators of the nicotinic effect. Once 
internalized and in the blood stream, nicotine is free to complex with nAChRs. These 
transmembrane, ligand-gated ion channels are the main mediators behind nicotine’s 
cellular effects [20]. Nicotine, a nAChR agonist, activates the receptor, which causes an 
opening of the transmembrane ionic channel and a subsequent influx of extracellular 
ions [22, 23]. Although all nAChRs serve the same basic purpose (i.e., transmembrane 
ion flux), the downstream implications initiated by receptor activation are dependent 
on the specific combination of subunits used to compose each nAChR. To date, 16 
unique subunit varieties have been identified in the mammalian species [20–22]. 
Functional nAChRs are composed of five subunits and classified as either homopen-
tameric, if subunits are identical, or heteropentameric, if subunits are nonidentical 
[20]. The homopentameric α7 nAChR has recently been identified on PDLSCs. In the 
presence of nicotine, these cells experience an increase in apoptosis and a decrease 
in migratory and osteogenic potential [23–27]. Interestingly, these effects were only 
partially inhibited (~40–50%) in cells pretreated with mecamylamine, a non-specific 
nAChR antagonist, and alpha bungarotoxin (aBTX), an α7-specific nAChR antagonist 
[26, 27]. Others have shown that similar nicotinic effects of PDLSC regeneration 
potential by decreasing proliferation, migration, and osteogenic differentiation 
capabilities in vitro are mediated through agonist-induced activation of α7 nicotinic 
acetylcholine receptors (nAChRs) present on PDLSCs [26, 27]. However, the detri-
mental effects of nicotine were still partially observed even after the deactivation of 
these receptors [27], suggesting that there may be additional mediators behind these 
effects. This data suggests that additional mechanisms are likely to exist as evident by 
the only partial reversal of nicotinic effects in the presence of nAChR antagonists.
1.3 MicroRNAs (miRNAs)
miRNAs are 22-nucleotide-long small, noncoding RNAs which may alter 
gene expression by base pairing with complementary mRNA [28, 29]. These 
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miRNAs are expressed throughout the body, including in muscular and skeletal 
tissues, and have been shown to affect cell viability, cell differentiation, and even 
organ development by downregulating the genes associated with these biological 
processes. Each miRNA can target several genes, and therefore upregulation of a 
single strand can affect various biological processes.
2. Biological effect of nicotine
We have published studies regarding the in vitro and in vivo biological and 
physiological effects of nicotine and CS on mesenchymal stem cells (MSCs) and 
PDLSCs. While investigating the effects of nicotine on the mechanical properties of 
MSCs, we concluded that nicotine significantly increases the stem cell membrane 
of Young’s modulus (i.e., stiffness) in a dose-dependent manner [30]. We predicted 
that this increase in stem cell stiffness would impair the ability of the stem cells 
to respond to mechanical stimuli, therefore hindering mechano-induction and 
ultimately stem cell differentiation potential. In addition, we predicted that the loss 
of membrane compliance would delay MSC migration from stem cell niches.
To investigate these consequences, we evaluated the effects of nicotine exposure 
on the three processes critical for effective stem cell regeneration potential: prolifera-
tion, migration, and differentiation [20]. In vitro exposure to nicotine significantly 
reduced the proliferation and migration potential of both MSC and PDLSCs [20]. 
MSC and PDLSC proliferation decreased significantly when culturing cells in media 
containing 1 μM of nicotine. In fact, by day 5, both nicotine-exposed groups showed 
greater than a twofold decrease in the total number of cells, indicating the loss of 
proliferative potential while exposed to nicotine. Mesenchymal stem cells (MSC) 
and PDLSCs exposed to nicotine also traveled shorter distances compared to non-
treated cells. The distance traveled by the nicotine-treated MSC was significantly 
shorter than that by the control MSC. The average speed of MSC migration was 
also slower in the nicotine-treated group than in the control group. Analogously, 
the nicotine-treated PDLSC migrated less than the control PDLSC. Furthermore, 
the nicotine-treated PDLSC also moved slower than the control PDLSC. Nicotine 
critically affected the differentiation potential of MSCs and PDLSCs [18, 19]. Under 
conditioned media stimulation, MSC and PDLSC differentiated into osteoblasts, and 
their calcium deposition increased. However, the osteogenic differentiation medium 
supplemented with nicotine reduced calcium deposition as evident by a decrease in 
MSC and PDLSC alkaline phosphatase activity. Altogether, these findings suggest 
that nicotine can inhibit the differentiation of osteoblasts from MSC or PDLSC.
To understand the molecular mechanism of the nicotine-induced effect, we 
also analyzed the global miRNA expression patterns of nicotine-treated PDLSC 
by microarray. A total of 225 miRNAs were differentially expressed at a twofold 
difference between nicotine-treated PDLSC when compared with the control [20]. 
The miRNA expression profiles of the control and 1.0 μM nicotine-treated groups 
were differentially clustered and separated from each other by either principle 
component analysis or hierarchical clustering. Compared to the control group, 
16 miRNAs were differentially expressed in the 1.0 μM nicotine group (Pcorr < 0.05 
and fold change >2). All of these miRNAs showed dose-dependent changes from 0.5 
to 1.0 μM nicotine. The top 10 highly expressed miRNAs were selected for valida-
tion and showed a similar expression change to the microarray results. Interestingly, 
five miRNAs related to osteogenesis (hsa-miR-29b, hsa-miR-30d, hsa-miR-137, 
hsa-miR-424, and hsa-miR-1274a) showed Pcorr < 0.05.
We confirmed these results also occur in vivo and showed that PDLSCs isolated 
from cigarette smokers showed similar trends in proliferation, migration, and 
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differentiation potentials and miRNA expression [21]. The proliferation of PDLSC 
from smokers was significantly slower than those of non-smokers by 2.53-fold at 
day 5 (p < 0.01) and 2.88-fold at day 7 (p < 0.05). In cell migration analysis, con-
ducted by scratch wound assay, smoker PDLSCs moved slower than the non-smoker 
PDLSCs. The reduction of scratch wound area by smoker PDLSC was smaller than 
that by non-smoker PDLSC at 12 hours (20.07 +/− 3.78% versus 25.92 +/− 4.00%, 
p < 0.05) and at 24 hours (60.10 +/− 8.55% versus 72.27 +/− 5.90%, p < 0.05), 
suggesting that CS reduces the migration ability of PDLSC. Cigarette smoking (CS) 
also inhibited osteogenic differentiation as seen by a reduction in alkaline phospha-
tase and Alizarin S Red and chondrocyte differentiation as indicated by the blue 
stain of acidic polysaccharides [21].
We also examined the expression of the top 10 differentially expressed miRNAs 
identified in our previous report. Interestingly, the miRNA profile of cigarette 
smokers showed similar trends in expression for the majority of the miRNAs. 
A miRNA-gene target list was subsequently generated for two of the similarly 
upregulated miRNAs, hsa-miR-1305 (629 target genes) and hsa-miR-18b (202 
target genes), using TargetScan in the GeneSpring software (Agilent). We used the 
Database for Annotation, Visualization, and Integrated Discovery (DAVID) to 
perform gene ontology analysis of the gene lists. We identified smoking-associ-
ated miRNAs (hsa-miR-1305 and hsa-miR-18b) might target the genes involved 
in cell cycle, cell projection, cell junction, and cytoskeleton. This suggested that 
cigarette smoking would account for the negative influence on PDLSC prolif-
eration and migration potential [21].
It is important to note that these effects persisted given that PDLSCs from smok-
ers underwent numerous cell passages after isolation (i.e., four and eight passages, 
splitting cells 1:3) and that all experiments using these cells were conducted in the 
absence of exogenous nicotine [21]. Accordingly, we concluded that these miRNAs, 
and not the nicotine receptors, play an important role in an inhibitory effect on 
stem cell regenerative potential and the long-term deteriorative effects of CS on 
stem cells.
Others have shown that similar nicotinic effects of PDLSC regeneration poten-
tial by decreasing proliferation, migration, and osteogenic differentiation capabili-
ties in vitro are mediated through agonist-induced activation of α7 nAChRs present 
on PDLSCs [26, 27]. However, the detrimental effects of nicotine were still partially 
observed even after the deactivation of these receptors [27], suggesting that there 
may be additional mediators behind these effects. These results hint at a possible 
mechanism for the nicotine-induced effects on PDLSC regeneration potential that 
involves both nAChRs and miRNA. A link between the nicotinic effect and the 
miRNA expression has yet to be fully determined; however, there does appear to be 
a correlation between the two.
Electronic cigarettes (ECs) are marketed as a “safer” alternative to cigarette 
smoking due to the significant reduction in toxic chemical exposure. Experienced EC 
users, however, are still capable of achieving cigarette-like levels of exposure to vapor 
compounds like nicotine, especially in the oral cavity—the initial site of exposure. 
Nicotine alone has been shown to significantly impact the osteogenic differentia-
tion potential of PDLSCs [16, 17], but its effect in tandem with additional EC vapor 
(ECV) compounds remains unknown. PDLSCs were cultured in osteogenic media 
supplemented with EC vapor extract. EC vapor (ECV) was generated by VitroCell’s 
VC1 automated vaping robot using an eVic EC filled with 50%/50% (w/v) PG/VG, 
0 or 36 mg/ml nicotine, and non-flavored e-liquid. Nicotine vapor content was deter-
mined to a final, physiological concentration of 1 or 10 μM nicotine.
EC condition media containing 10 μM reduced osteogenic differentia-
tion. In comparison, CS blocks mineralization significantly more than EC in a 
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dose—response fashion. The greatly enhanced inhibitory effect of CS may be due 
to the 7000 other chemicals besides nicotine. miRNA microarray analysis showed 
that 1 μM nicotine ECV treatments upregulated miRNA (i.e., hsa-miR-29b (4.15-
fold, p < 0.05), hsa-miR-424 (2.10-fold, p < 0.05), and hsa-miR-30d (3.18-fold, 
p < 0.05)) targeted genes related to osteogenesis. After 7 days of induction, high 
concentrations of nicotine ECV suppressed the gene expression of early osteogenic 
differentiation markers RUNX2, ALPL, and COL1A1 by >25%. Nicotine ECV also 
suppressed mineralized nodule formation after 21 days in a dose-dependent man-
ner. In comparison, cigarette smoking is tenfold inhibitory than ESC. This may be 
attributed to over 7000 other toxic chemicals in CS. Our pilot study is the first to 
investigate the potential effects of ECV by influencing the osteogenic differentia-
tion potential of PDLSCs. A further understanding of the consequences of ECV on 
adult stem cell health is imperative given the rapid rise of EC use and routine use of 
postnatal stem cells in regenerative applications [31–33].
3. Conclusion
In conclusion, stem cells are effective for the treatment of a variety of injuries 
and diseases. However, compromising stem cell function, through infectious or 
genetic diseases, can lead to ineffective clinical outcomes. Literature reports sug-
gested that smoking effects of stem cell regeneration potential by decreasing prolif-
eration, migration, and osteogenic differentiation capabilities in vitro are mediated 
through agonist-induced activation of α7 nAChRs present on PDLSCs [26, 27].
Our work focuses on the determination of the potential harmful effect of smok-
ing on the regenerative capabilities of stem cells and the mediators behind these 
effects. We showed that smoking suppression of stem cell potentials by miRNAs is a 
separate and independent pathway than the pathway via the α7 nAChR activation. 
Smoking perturbs miRNA expression, resulting in decreased PDLSC regeneration 
potential that delays healing of smoking-induced periodontitis.
This contribution will be significant because it will provide much needed data 
regarding smoking as well as consequences of vaping on oral cell/tissue health. 
Moreover, the data gathered as part of this work has the potential to be used in 
future commercial applications such as the development of a prescreening method 
or an early detection system for destructive oral diseases such as periodontitis.
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